i
Traveler-based genomic surveillance for early detection of new SARS-CoV-2 variants Surveillance for Early Detection of New SARS-CoV-2 Variants
-
10/27/2023
Details:
-
Corporate Authors:
-
Description:What’s New in TGS: In preparation for fall/winter respiratory season, TGS launched a nasal sampling multipathogen pilot, which will test for Flu A/B, RSV, SARS-CoV-2, and other respiratory pathogens.
The Traveler-based Genomic Surveillance program (TGS), led by CDC’s Travelers’ Health Branch, is a public-private partnership that plays an important role in U.S. national biosecurity through its two major goals:
1. early detection of new SARS-CoV-2 variants and other pathogens and
2. filling in gaps in global biosurveillance.
-
Subjects:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: